Ipamorelin 10mg Sterling Knight

£89.00

Ipamorelin 10mg Sterling Knight is a synthetic pentapeptide growth hormone secretagogue designed for in-vitro research applications studying growth hormone release pathways and cellular mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ipamorelin 10mg Sterling Knight
Ipamorelin 10mg Sterling Knight
£89.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Ipamorelin 10mg Sterling Knight

Ipamorelin 10mg Sterling Knight is a synthetic pentapeptide growth hormone secretagogue specifically engineered for laboratory research applications. This selective ghrelin receptor agonist demonstrates unique binding characteristics that make it valuable for researchers at Stroid UK Shop investigating growth hormone release mechanisms and cellular signalling pathways. The Sterling Knight formulation provides researchers with a consistent 10mg peptide preparation suitable for comprehensive in-vitro studies examining growth hormone secretagogue receptor interactions.

Laboratory Research Applications

Research scientists utilise Ipamorelin in controlled laboratory environments to examine growth hormone release patterns and cellular responses. Studies focus on investigating the peptide’s selective binding properties to ghrelin receptors and subsequent intracellular signalling cascades. Laboratory protocols examine how this compound influences growth hormone secretion without affecting cortisol or prolactin pathways, making it distinct from other growth hormone releasing peptides available in our losing weight peptides category. Researchers analyse the compound’s pharmacokinetic properties and receptor selectivity profiles in cellular assays. Comparative studies evaluate Ipamorelin against other research compounds found in our SARMs collection to understand different growth factor pathways. Laboratory investigations examine the peptide’s stability characteristics and optimal storage conditions for maintaining research integrity. Scientists study the compound’s molecular interactions with various receptor subtypes and downstream signalling molecules. Research protocols investigate cellular uptake mechanisms and intracellular distribution patterns. Studies analyse the compound’s effects on cellular metabolism and protein synthesis pathways in controlled laboratory conditions. Researchers examine how Ipamorelin compares to other growth hormone secretagogues in our comprehensive peptides research range for mechanistic studies.

Technical Specifications

Ipamorelin 10mg Sterling Knight Research Specifications
Parameter Specification
Molecular Formula C38H49N9O5
Molecular Weight 711.85 g/mol
CAS Number 170851-70-4
Peptide Content 10mg per vial
Purity ≥98% HPLC
Storage Temperature -20°C

Research Compliance Notice

Ipamorelin 10mg Sterling Knight is manufactured exclusively for in-vitro research purposes and laboratory studies. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper handling protocols and laboratory safety measures when conducting studies with this compound.

Related